MedTrace Logo

Drug-drug Interaction Study With MDV3100 (ASP9785) and Gemfibrozil and Itraconazole

NCT01913379 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2013-08-01

No results posted yet for this study

Summary

A study to assess possible drug-drug interactions between MDV3100 and gemfibrozil and MDV3100 and Itraconazole.

Conditions

  • Healthy Subjects
  • Pharmacokinetics
  • Drug-Drug Interaction

Interventions

DRUG

MDV3100

Oral

DRUG

Gemfibrozil

Oral

DRUG

Itraconazole

Oral

Sponsors & Collaborators

  • Medivation, Inc.

    collaborator INDUSTRY

  • Astellas Pharma Europe B.V.

    lead INDUSTRY

Principal Investigators

  • Operation Senior Research Manager · Astellas Pharma Europe B.V.

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01913379 on ClinicalTrials.gov